---
document_datetime: 2023-09-21 21:43:02
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/temozolomide-hexal-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: temozolomide-hexal-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.2813798
conversion_datetime: 2025-12-14 23:05:31.051054
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Temozolomide Hexal

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on product   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0037              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 24/05/2022                                  |                                             | SmPC, Labelling and PL           |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions

are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

Medicinal product no longer authorised

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0036   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                | 02/03/2021         | n/a           | authorised                       |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|---------------|----------------------------------|
| IB/0035   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 06/07/2020         | 30/09/2020    | SmPC, Annex II, Labelling and PL |
| IAIN/0034 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 27/09/2019         | 30/09/2020    | SmPC longer                      |
| IB/0033   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 19/06/2018         | 06/06/2019 no | SmPC, Labelling and PL           |
| IB/0032   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                 | 18/05/2018 product | 06/07/2018    | SmPC and PL                      |
| IA/0031   | B.II.b.4.b - Change in the batch size (including batch size ranges) of the finished product - Downscaling down to 10-fold Medicinal                                                                                                                          | 22/02/2018         | n/a           |                                  |
| IB/0030   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 17/07/2017         | 06/07/2018    | SmPC, Labelling and PL           |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| IAIN/0029   | B.III.2.a.1 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of a Member State - AS                                                                                                                                                                                                                                                     | 20/01/2017   | n/a        |                   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------|
| IB/0028/G   | This was an application for a group of variations. B.II.e.1.a.1 - Change in immediate packaging of the finished product - Qualitative and quantitative composition - Solid pharmaceutical forms B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- sterile medicinal products B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non- | 11/10/2016   | n/a        | longer authorised |
| IA/0027     | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                       | 07/10/2016   | n/a no     |                   |
| IA/0026     | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) product                                                                                                                                                                                                                           | 23/03/2016   | n/a        |                   |
| IB/0025     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by Medicinal                                                                                                                                                                     | 14/07/2015   | 15/07/2016 | SmPC and PL       |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |            |                    |                                                                                                                                                                                                                                                                                                                                                                                                                         |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0024 | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 18/12/2014 | n/a                | authorised                                                                                                                                                                                                                                                                                                                                                                                                              |
| R/0022  | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 25/09/2014 | 19/11/2014 SmPC    | and PL Based on the review of the available information, the CHMP is of the opinion that the quality, the safety and the efficacy of this medicinal product continues to be adequately and sufficiently demonstrated and therefore considers the benefit/risk profile of Temozolomide Hexal continues to be favourable. The CHMP is also of the opinion that the renewal can be granted with unlimited validity. longer |
| IB/0023 | Update of section 4.8 of the SmPC to include the calculated frequency of hepatic-related disorders following adoption of the same changes for the reference product. Section 4 of the Package Leaflet was updated accordingly. In addition, the MAH took the opportunity to align the PI to the reference product, introduce minor editorial changes, add missing QRD updates. C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH Medicinal product | 08/08/2014 | 19/11/2014 SmPC no | and PL                                                                                                                                                                                                                                                                                                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| II/0020     | Broaden the limit for one impurity in the finished product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 24/07/2014   | n/a                  |                                   |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|----------------------|-----------------------------------|
| IAIN/0021/G | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes Medicinal product | 08/05/2014   | 19/11/2014 no longer | SmPC, Labelling and PL authorised |
| IAIN/0019/G | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 07/05/2014   | 19/11/2014           | SmPC,                             |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|         | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes   |                    |               | Labelling and PL authorised             |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|---------------|-----------------------------------------|
| IB/0018 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                            | 13/03/2014         | 19/11/2014    | SmPC, Annex II, Labelling and PL longer |
| IB/0017 | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                          | 10/04/2013 product | 13/12/2013 no | SmPC and PL                             |
| IA/0016 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                            | 07/02/2013         | n/a           |                                         |
| IB/0015 | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) Medicinal                                                                                                                                                     | 19/12/2012         | 13/12/2013    | SmPC                                    |
| IB/0014 | C.I.2.a - Change in the SPC, Labelling or PL of a                                                                                                                                                                                                                                                       | 05/09/2012         | 25/10/2012    | SmPC,                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data are submitted by the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |            |               | Labelling and PL authorised   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------|-------------------------------|
| IB/0012   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 14/06/2012 | 25/10/2012    | SmPC                          |
| IB/0011/G | This was an application for a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.e.1.b.1 - Change in immediate packaging of the finished product - Type of container - Solid, semi- solid and non-sterile liquid pharmaceutical forms B.II.e.1.b.1 - Change in immediate packaging of the finished product - Type of container - Solid, semi- solid and non-sterile liquid pharmaceutical forms B.II.e.1.b.1 - Change in immediate packaging of the finished product - Type of container - Solid, semi- solid and non-sterile liquid pharmaceutical forms Medicinal product | 23/03/2012 | 15/06/2012 no | SmPC, Labelling and PL longer |

<div style=\"page-break-after: always\"></div>

<!-- image -->

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | product) of a specification parameter as a result of a safety or quality issue                                                                                                                                                                  |            |               |                                             |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------|---------------------------------------------|
| IB/0009   | C.I.2.z - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Other variation                                                                        | 15/12/2011 | 15/06/2012    | SmPC, Annex II, Labelling and PL authorised |
| IB/0007   | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                                                                         | 22/11/2011 | 15/06/2012    | SmPC                                        |
| II/0005   | To increase the shelf life specification limit of the finished product for some impurities. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range | 21/07/2011 | 21/07/2011 no | longer                                      |
| IA/0006   | C.I.9.i - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) to a DDPS following the assessment of the same DDPS in relation to another medicinal product of the same MAH product                             | 20/07/2011 | n/a           |                                             |
| II/0004/G | This was an application for a group of variations. To reduce the amount of desiccant and to replace the desiccant disc with a desiccant pouch. To add the special storage condition \"Do not store above 25Â°C\". Medicinal                        | 14/04/2011 | 23/06/2011    | SmPC, Annex II, Labelling and PL            |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | To reduce the shelf-life from 2 years to 1 year. To change the medicinal product's release and shelf- life specification To delete all HDPE bottle presentations (EU/1/10/616/003, 004, 007, 008, 011, 012, 015, 016, 019, 020, 023, 024). In addition, the MAH has taken the opportunity to delete the version number of the DDPS in Annex II. B.II.e.1.z - Change in immediate packaging of the finished product - Other variation B.II.e.5.b - Change in pack size of the finished product - Deletion of a pack size(s)   | longer authorised   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|
| IB/0003/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate product           | 05/08/2010 n/a no   |
| IA/0001   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site Medicinal                                                                                                                                                                                                                                                                                                                                                                                                                 | 18/06/2010 n/a      |

<div style=\"page-break-after: always\"></div>

<!-- image -->